Compound 2045
Identifiers
- Canonical SMILES:
C[C@H]1CN(C(=O)C2CC2)c2cc(ccc2N1C(C)=O)-c1cnn(c1)C1COC1
- IUPAC name:
1-[(2S)-4-cyclopropanecarbonyl-2-methyl-6-[1-(oxetan-3-yl)-1H-pyrazol-4-yl]-1,2,3,4-tetrahydroquinoxalin-1-yl]ethan-1-one
- InChi:
InChI=1S/C21H24N4O3/c1-13-9-23(21(27)15-3-4-15)20-7-16(5-6-19(20)25(13)14(2)26)17-8-22-24(10-17)18-11-28-12-18/h5-8,10,13,15,18H,3-4,9,11-12H2,1-2H3/t13-/m0/s1
- InChiKey:
IZGKRXAIBAPJKA-ZDUSSCGKSA-N
External links
![]() 118078883 |
![]() CHEMBL4211739 |
External search
|
|
|
|
|
Bibliography (1)
Pharmacological data
| Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|
| 1 | 1 | 0 | 0 |
Targets
| PPI family | Best activity | Diseases | MMoA |
|---|---|---|---|
| Bromodomain / Histone | 6.43 | cancer | Inhibition |
Physicochemical filters
| Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
|---|---|---|---|---|
| Compliance | ||||
| MW | 380.18 g/mol | |||
| HBA | 7 | |||
| HBD | 0 | |||
| HBA + HBD | 7 | |||
| AlogP | 1.12 | |||
| TPSA | 67.67 | |||
| RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
| Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|---|
| 1 | 1 | 1 | 0 | 0 |
Pharmacological data
| Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
|---|---|---|---|---|---|---|---|---|
| 10.1021/acsmedchemlett.7b00191 | compound 18 | BRD4 Q9ESU6 |
H33 P84243 |
Biochemical assay | alphascreen BRD4 | pIC50 (half maximal inhibitory concentration, -log10) | 6.43 | |
| 10.1021/acsmedchemlett.7b00191 | compound 18 | BRD4 Q9ESU6 |
H33 P84243 |
Cellular assay | cellular viability MV4-11 | MV4-11 | pIC50 (half maximal inhibitory concentration, -log10) | 6.36 |
| Ta | Structure | Name | Drugbank ID |
|---|---|---|---|
| 0.4591 | 1-[4-Carboxy-2-(3-Pentylamino)Phenyl]-5,5'-Di(Hydroxymethyl)Pyrrolidin-2-One | DB03475 | |
| 0.4327 | N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE | DB07059 | |
| 0.4319 | Ilorasertib | DB11694 | |
| 0.4315 | 4-(N-ACETYLAMINO)-3-[N-(2-ETHYLBUTANOYLAMINO)]BENZOIC ACID | DB07762 | |
| 0.4302 | 4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE | DB08087 | |
| 0.4236 | Nefiracetam | DB13082 | |
| 0.4184 | Etidocaine | DB08987 | |
| 0.4158 | 4SC-202 | DB13101 | |
| 0.4124 | Delparantag | DB12955 | |
| 0.4122 | Ropivacaine | DB00296 | |
| 0.4122 | Bupivacaine | DB00297 | |
| 0.4122 | Levobupivacaine | DB01002 | |
| 0.4112 | Volasertib | DB12062 | |
| 0.4107 | Acebutolol | DB01193 | |
| 0.4088 | GI-181771X | DB12309 |




